These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6717898)

  • 1. Phase II study of Lonidamine in cancer patients.
    Band PR; Deschamps M; Besner JG; Leclaire R; Gervais P; De Sanctis A
    Oncology; 1984; 41 Suppl 1():66-8. PubMed ID: 6717898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I toxicologic study of Lonidamine in cancer patients.
    Band PR; Deschamps M; Besner JG; Leclaire R; Gervais P; De Sanctis A
    Oncology; 1984; 41 Suppl 1():56-9. PubMed ID: 6717896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II evaluation of Lonidamine in patients with advanced malignancy.
    Evans WK; Shepherd FA; Mullis B
    Oncology; 1984; 41 Suppl 1():69-77. PubMed ID: 6717899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of lonidamine in inoperable non-small-cell lung cancer.
    Kokron O; Maca S; Scheiner W; De Gregorio M; Ciottoli GB
    Oncology; 1984; 41 Suppl 1():86-9. PubMed ID: 6717902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.
    Band PR; Maroun J; Pritchard K; Stewart D; Coppin CM; Wilson K; Eisenhauer EA
    Cancer Treat Rep; 1986 Nov; 70(11):1305-10. PubMed ID: 3768873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of lonidamine in metastatic breast cancer.
    Pronzato P; Amoroso D; Bertelli G; Conte PF; Cusimano MP; Ciottoli GB; Gulisano M; Lionetto R; Rosso R
    Br J Cancer; 1989 Feb; 59(2):251-3. PubMed ID: 2930690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I and clinical pharmacologic evaluation of Lonidamine in patients with advanced cancer.
    Young CW; Currie VE; Kim JH; O'Hehir MA; Farag FM; Kinahan JE
    Oncology; 1984; 41 Suppl 1():60-5. PubMed ID: 6717897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early observations on the administration of Lonidamine in cancer patients.
    Barduagni A; Barduagni M; Di Lauro L; Nardi M; Gallo Curcio C; Tonachella R; Ciottoli GB; Delle Chiaie S
    Oncology; 1984; 41 Suppl 1():78-81. PubMed ID: 6717900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of lonidamine in patients with small cell carcinoma of the lung.
    Murray N; Shah A; Band P
    Cancer Treat Rep; 1987 Dec; 71(12):1283-4. PubMed ID: 2825992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
    Weinerman BH; Eisenhauer EA; Besner JG; Coppin CM; Stewart D; Band PR
    Cancer Treat Rep; 1986 Jun; 70(6):751-4. PubMed ID: 3524824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of lonidamine with whole body hyperthermia in advanced cancer.
    Robins HI; Longo WL; Lagoni RK; Neville AJ; Hugander A; Schmitt CL; Riggs C
    Cancer Res; 1988 Nov; 48(22):6587-92. PubMed ID: 3180069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lonidamine in advanced colorectal cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC).
    Passalacqua R; Bisagni G; Bertusi M; Donati D; Buzzi F; Di Costanzo F; Basurto C; Gori S
    Tumori; 1989 Jun; 75(3):277-9. PubMed ID: 2672481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic administration of lonidamine in untreated non-small cell lung cancer of stage III M0-1.
    Scagliotti GV; Gozzelino F; Albera C; Pescetti G
    Chemotherapy; 1989; 35(1):64-8. PubMed ID: 2541978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined use of radiation therapy and lonidamine in the treatment of brain metastases.
    DeAngelis LM; Currie VE; Kim JH; Krol G; O'Hehir MA; Farag FM; Young CW; Posner JB
    J Neurooncol; 1989 Sep; 7(3):241-7. PubMed ID: 2677257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lonidamine alone and in combination with other chemotherapeutic agents in the treatment of cancer patients.
    Pacilio G; Carteni G; Biglietto M; De Cesare M
    Oncology; 1984; 41 Suppl 1():108-12. PubMed ID: 6326014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II study.
    Stahl M; Schmoll E; Becker H; Schlichter A; Hoffmann L; Wagner H; Possinger K; Müller W; Köllermann M; Weidenhammer W
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):33-7. PubMed ID: 2031196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group study.
    Robins HI; Neuberg DS; Benson AB; Pandya KJ; Tormey DC
    Invest New Drugs; 1990 Nov; 8(4):397-9. PubMed ID: 2084074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lonidamine in primary malignant brain tumors. Preliminary report.
    Carapella CM; Iandolo B; Delle Chiaie S; Riccio A
    Oncology; 1984; 41 Suppl 1():82-5. PubMed ID: 6717901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of lonidamine in non-small cell lung cancer: final report.
    Kokron O; Maca S; De Gregorio M; Ciottoli GB
    Br J Cancer; 1990 Feb; 61(2):316-8. PubMed ID: 2155644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II clinical and pharmacokinetic study of Lonidamine in patients with advanced breast cancer.
    Mansi JL; de Graeff A; Newell DR; Glaholm J; Button D; Leach MO; Payne G; Smith IE
    Br J Cancer; 1991 Sep; 64(3):593-7. PubMed ID: 1911204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.